首页|期刊导航|国际医药卫生导报|甲泼尼龙冲击治疗对复发缓解型多发性硬化患者血清中IL-23及IL-17A水平的影响

甲泼尼龙冲击治疗对复发缓解型多发性硬化患者血清中IL-23及IL-17A水平的影响OA

Effect of methylprednisolone pulse therapy on serum IL-23 and IL-17A levels in patients with relapsing-remitting multiple sclerosis

中文摘要英文摘要

目的 分析甲泼尼龙冲击治疗对复发缓解型多发性硬化患者血清中IL-23及IL-17A水平的影响,为临床治疗复发缓解型多发性硬化提供参考.方法 选取我院2013年1月至2016年6月收治的52例复发缓解型多发性硬化患者作为观察组,并给予甲泼尼龙冲击治疗,选取同期于我院进行健康体检的52例志愿者作为对照组,比较两组阳性检出率、血清和脑脊液IL-23和IL-17A水平.结果 观察组治疗前血清中IL-23、IL-17A阳性检出率高于对照组,差异有统计学意义…查看全部>>

Objective To investigate the effect of methylprednisolone pulse therapy on serum IL-23 and IL-17A levels in patients with relapsing-remitting multiplc sclerosis (RRMS),and provide reference for clinical treatment of RRMS.Methods 52 patients with RRMS in our hospital from January 2013 to June 2016 were selected as observation group,and given methylprednisolone pulse therapy.52 healthy peoples during the same period were selected as control group.Compared the …查看全部>>

田士宏;吕苏花;侯传龙

277000 枣庄矿业集团中心医院神经内科277000 枣庄矿业集团中心医院神经内科277000 枣庄矿业集团中心医院神经内科

复发缓解型多发性硬化甲泼尼龙IL-23IL-17A

Relapsing-remitting multiple sclerosisMethylprednisoloneIL-23IL-17A

《国际医药卫生导报》 2016 (23)

3625-3627,3

10.3760/cma.j.issn.1007-1245.2016.23.029

评论

您当前未登录!去登录点击加载更多...